Treatment Emergent Adverse Event
A treatment emergent adverse event is a event that happens during treatment, having been absent pretreatment, or worsens relative to the pretreatment state. (CDISC)
Support Provided by AbbVie, Amgen, AstraZeneca, Bristol Myers Squibb, Eisai, Genentech, Merck, and Sanofi.
